Polydatin inhibits LPS-induced inflammatory response in BV2 microglia by disrupting the formation of lipid rafts

Shengyu Sun1, Yourui Zou1, Shaocai Hao1

  • 1Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, China.

Abstract

Insights

Polydatin reduces neuroinflammation by disrupting lipid rafts and inhibiting the PI3K/AKT pathway in microglia cells. This natural compound ameliorates inflammatory mediator production and NF-κB activation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Polydatin is recognized for treating inflammatory diseases.
  • Its specific role in neuroinflammation remains largely uninvestigated.
  • Microglia activation is central to neuroinflammation.

Purpose of the Study:

  • To investigate the anti-inflammatory effects of polydatin.
  • To explore polydatin's mechanism in LPS-stimulated BV2 microglia cells.

Main Methods:

  • Quantification of inflammatory mediators (TNF-α, IL-1β, NO, PGE2) via ELISA.
  • Western blot analysis to detect signaling pathway proteins.
  • Assessment of lipid raft formation and cholesterol content.

Main Results:

  • Polydatin significantly decreased LPS-induced TNF-α, IL-1β, NO, and PGE2 production.
  • Polydatin inhibited LPS-induced NF-κB activation by targeting the PI3K/AKT pathway.
  • Polydatin disrupted lipid raft formation and increased ABCA1/ABCG1 expression.

Conclusions:

  • Polydatin exerts anti-inflammatory effects in microglia.
  • Disruption of lipid rafts and subsequent inhibition of the PI3K/AKT pathway mediate polydatin's action.
  • Polydatin shows potential as a therapeutic agent for neuroinflammatory conditions.